Gonadotropins and ovarian cancer.

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Endocrine reviews

• Publication date

  2007-06-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1210/ER.2006-0036PMID 17463396
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Endocrine signaling in ovarian surface epithelium and cancer.

  2007cited by this paper
• Gonadotropin-induced superovulation drives ovarian surface epithelia proliferation in CD1 mice.

  2006cited by this paper
• Association between endometriosis and cancer: a comprehensive review and a critical analysis of clinical and epidemiological evidence.

  2006cited by this paper
• Differential regulation of two forms of gonadotropin-releasing hormone messenger ribonucleic acid by gonadotropins in human immortalized ovarian surface epithelium and ovarian cancer cells.

  2006cited by this paper
• Endometriosis as a model for inflammation-hormone interactions in ovarian and breast cancers.

  2006cited by this paper
• Single nucleotide polymorphisms of follicle-stimulating hormone receptor are associated with ovarian cancer susceptibility.

  2006cited by this paper
• Gonadotropins activate proteolysis and increase invasion through protein kinase A and phosphatidylinositol 3-kinase pathways in human epithelial ovarian cancer cells.

  2006cited by this paper
• Luteinizing hormone inhibits Fas-induced apoptosis in ovarian surface epithelial cell lines.

  2006cited by this paper
• Recent advances on multiple tumorigenic cascades involved in prostatic cancer progression and targeting therapies.

  2006cited by this paper
• Gonadotropin-induced apoptosis in human ovarian surface epithelial cells is associated with cyclooxygenase-2 up-regulation via the beta-catenin/T-cell factor signaling pathway.

  2006cited by this paper
• Genetic complexity of FSH receptor function.

  2005cited by this paper
• Wnt signalling in stem cells and cancer

  2005cited by this paper
• Histologic types of epithelial ovarian cancer: have they different risk factors?

  2005cited by this paper
• Single-nucleotide polymorphisms in the promoter region influence the expression of the human follicle-stimulating hormone receptor.

  2005cited by this paper
• Stem cell niche: structure and function.

  2005cited by this paper
• Gonadotropins Regulate N-cadherin-mediated Human Ovarian Surface Epithelial Cell Survival at Both Post-translational and Transcriptional Levels through a Cyclic AMP/Protein Kinase A Pathway*

  2005cited by this paper
• Phase II trial of tamoxifen and goserelin in recurrent epithelial ovarian cancer

  2005cited by this paper
• High follicular phase luteinizing hormone levels in young healthy BRCA1 mutation carriers: implications for breast and ovarian cancer risk.

  2005cited by this paper
• A common single nucleotide polymorphism in exon 10 of the human follicle stimulating hormone receptor is a major determinant of length and hormonal dynamics of the menstrual cycle.

  2005cited by this paper
• Loss of ovarian function and the risk of ovarian cancer

  2005cited by this paper
• Endogenous hormones and ovarian cancer: epidemiology and current hypotheses.

  2005cited by this paper
• Association of fetal hormone levels with stem cell potential: evidence for early life roots of human cancer.

  2005cited by this paper
• Inhibin resistance is associated with aggressive tumorigenicity of ovarian cancer cells.

  2005cited by this paper
• Stem and progenitor-like cells contribute to the aggressive behavior of human epithelial ovarian cancer.

  2005cited by this paper
• Expression of progesterone receptor is a favorable prognostic marker in ovarian cancer.

  2005cited by this paper
• Gonadotropins upregulate the epidermal growth factor receptor through activation of mitogen-activated protein kinases and phosphatidyl-inositol-3-kinase in human ovarian surface epithelial cells.

  2005cited by this paper
• Effect of anovulation factors on pre- and postmenopausal ovarian cancer risk: revisiting the incessant ovulation hypothesis.

  2005cited by this paper
• Gonadotropins and ovarian carcinogenesis: a new era of basic research and its clinical implications

  2005cited by this paper
• Ovarian Cancer Risk After the Use of Ovulation-Stimulating Drugs

  2004cited by this paper
• Assisted Reproductive Technology and the Incidence of Ovarian Cancer: A Meta-Analysis

  2004cited by this paper
• Second‐line therapy of advanced ovarian cancer with GnRH analogs

  2004cited by this paper
• Expression and regulation of luteinizing hormone/human chorionic gonadotropin receptors in ovarian cancer and its correlation to human chorionic gonadotropin-doxorubicin sensitivity.

  2004cited by this paper
• Focus on epithelial ovarian cancer.

  2004cited by this paper
• Anti-inflammatory and proliferative responses in human and ovine ovarian surface epithelial cells.

  2004cited by this paper
• FSH and LH serum/tumor fluid ratios and malignant tumors of the ovary.

  2004cited by this paper
• New Advances on the Functions of Epidermal Growth Factor Receptor and Ceramides in Skin Cell Differentiation, Disorders and Cancers

  2004cited by this paper
• Relation of contraceptive and reproductive history to ovarian cancer risk in carriers and noncarriers of BRCA1 gene mutations.

  2004cited by this paper
• Cytotoxic Effect of Conjugates of Doxorubicin and Human Chorionic Gonadotropin (hCG) in Breast Cancer Cells

  2004cited by this paper
• Oral contraceptive use, reproductive history, and risk of epithelial ovarian cancer in women with and without endometriosis.

  2004cited by this paper
• Follicle-stimulating Hormone Activation of Hypoxia-inducible Factor-1 by the Phosphatidylinositol 3-Kinase/AKT/Ras Homolog Enriched in Brain (Rheb)/Mammalian Target of Rapamycin (mTOR) Pathway Is Necessary for Induction of Select Protein Markers of Follicular Differentiation*

  2004cited by this paper
• Body size and ovarian cancer: case–control study and systematic review (Australia)

  2004cited by this paper
• Gonadotropin-induced gene regulation in human granulosa cells obtained from IVF patients: modulation of genes coding for growth factors and their receptors and genes involved in cancer and other diseases.

  2004cited by this paper
• Characterization of a Carcinogenesis Rat Model of Ovarian Preneoplasia and Neoplasia

  2004cited by this paper
• Follicle stimulating hormone‐induced growth promotion and gene expression profiles on ovarian surface epithelial cells

  2004cited by this paper
• Cigarette smoking and risk of epithelial ovarian cancer (Australia)

  2004cited by this paper
• Ovarian cancer risk after the use of ovulation-stimulating drugs.

  2004cited by this paper
• Menopause and hypothalamic-pituitary sensitivity to estrogen.

  2004cited by this paper
• Expression of beta-human chorionic gonadotropin in ovarian cancer tissue.

  2004cited by this paper
• Gonadotropins mediate DNA synthesis and protection from spontaneous cell death in human ovarian surface epithelium

  2004cited by this paper
• Gonadotropin (LH, FSH) levels in serum and cyst fluid in epithelial tumors of the ovary

  2004cited by this paper
• Sex-steroid hormones, gonadotropin and ovarian carcinogenesis: a review of epidemiological and experimental data

  2004cited by this paper
• Human Follicle-Stimulating Hormone (FSH) Receptor Interacts with the Adaptor Protein APPL1 in HEK 293 Cells: Potential Involvement of the PI3K Pathway in FSH Signaling1

  2004cited by this paper
• Gonadotropin and steroid hormones stimulate proliferation of the rat ovarian surface epithelium

  2004cited by this paper
• Overexpression of follicle-stimulating hormone receptor activates oncogenic pathways in preneoplastic ovarian surface epithelial cells.

  2004cited by this paper
• Roles of luteinizing hormone/chorionic gonadotropin receptor in anchorage‐dependent and ‐independent growth in human ovarian surface epithelial cell lines

  2003cited by this paper
• Alcohol Consumption and the Risk of Mucinous and Nonmucinous Epithelial Ovarian Cancer

  2003cited by this paper
• Luteinizing hormone in peritoneal and ovarian cyst fluids: a predictor of ovarian carcinoma.

  2003cited by this paper
• Pathology and classification of ovarian tumors

  2003cited by this paper
• Cyclic AMP induces integrin-mediated cell adhesion through Epac and Rap1 upon stimulation of the β2-adrenergic receptor

  2003cited by this paper
• Follicle-stimulating hormone promotes nuclear exclusion of the forkhead transcription factor FoxO1a via phosphatidylinositol 3-kinase in porcine granulosa cells.

  2003cited by this paper
• Serum follicle-stimulating hormone and risk of epithelial ovarian cancer in postmenopausal women.

  2003cited by this paper
• Role and Gonadotrophic Regulation of X-Linked Inhibitor of Apoptosis Protein Expression During Rat Ovarian Follicular Development In Vitro1

  2003cited by this paper
• High levels of luteinizing hormone analog stimulate gonadal and adrenal tumorigenesis in mice transgenic for the mouse inhibin-α-subunit promoter/Simian virus 40 T-antigen fusion gene

  2003cited by this paper
• Loss of surface and cyst epithelial basement membranes and preneoplastic morphologic changes in prophylactic oophorectomies

  2003cited by this paper
• Effects of ovulation induction on ovarian morphology: an animal study

  2003cited by this paper
• [Protective effect of follicle stimulating hormone on apoptosis of human epithelial ovarian cancer cell induced by cisplatin].

  2003cited by this paper
• Survival and Prognostic Factors in Patients With Ovarian Cancer

  2003cited by this paper
• Ovarian cancer associated with inherited mutations in BRCA1 or BRCA2.

  2003cited by this paper
• Quantitative analysis of follicle‐stimulating hormone receptor in ovarian epithelial tumors: A novel approach to explain the field effect of ovarian cancer development in secondary mullerian systems

  2003cited by this paper
• Carcinoma of the ovary

  2003cited by this paper
• Phase II study of cetrorelix, a luteinizing hormone-releasing hormone antagonist in patients with platinum-resistant ovarian cancer.

  2003cited by this paper
• GnRH analogues as an adjuvant therapy for ovarian cancer patients

  2003cited by this paper
• The Expression of hCG Receptor mRNA in Four Human Ovarian Cancer Cell Lines Varies Considerably under Different Experimental Conditions

  2003cited by this paper
• Implementation of the Women's Health Initiative study design.

  2003cited by this paper
• Profiling follicle stimulating hormone-induced gene expression changes in normal and malignant human ovarian surface epithelial cells

  2003cited by this paper
• [Follicle stimulating hormone inhibits cisplatin induced apoptosis in ovarian cancer cells].

  2003cited by this paper
• Cigarette Smoking and the Risk of Mucinous and Nonmucinous Epithelial Ovarian Cancer

  2002cited by this paper
• Effects of a lytic peptide conjugated to beta HCG on ovarian cancer: studies in vitro and in vivo.

  2002cited by this paper
• Follicle-stimulating hormone activates mitogen-activated protein kinase in preneoplastic and neoplastic ovarian surface epithelial cells.

  2002cited by this paper
• Infertility, fertility drugs, and ovarian cancer: a pooled analysis of case-control studies.

  2002cited by this paper
• Cancer incidence following treatment for infertility at a clinic in the UK.

  2002cited by this paper
• Chemotherapy versus hormonal treatment in platinum- and paclitaxel-refractory ovarian cancer: a randomised trial of the German Arbeitsgemeinschaft Gynaekologische Onkologie (AGO) Study Group Ovarian Cancer.

  2002cited by this paper
• FSH-regulated gene expression profiles in ovarian tumours and normal ovaries.

  2002cited by this paper
• Determinants of early follicular phase gonadotrophin and estradiol concentrations in women of late reproductive age.

  2002cited by this paper
• Long‐term effects of oral contraceptives on ovarian cancer risk

  2002cited by this paper
• Characterization of human chorionic gonadotropin as a novel angiogenic factor.

  2002cited by this paper
• No rules without exception: long-term complete remission observed in a study using a LH-RH agonist in platinum-refractory ovarian cancer.

  2002cited by this paper
• Human chorionic gonadotropin suppresses ovarian epithelial neoplastic cell proliferation in vitro.

  2002cited by this paper
• VEGF expression and enhanced production by gonadotropins in ovarian epithelial tumors

  2002cited by this paper
• Hormone replacement therapy and the risk of invasive epithelial ovarian cancer in Swedish women.

  2002cited by this paper
• Reproductive hormone-induced, STAT3-mediated interleukin 6 action in normal and malignant human ovarian surface epithelial cells.

  2002cited by this paper
• Inhibin-activin receptor subunit gene expression in ovarian tumors.

  2002cited by this paper
• Differential Expression of Progesterone Receptor Isoforms A and B in the Normal Ovary, and in Benign, Borderline, and Malignant Ovarian Tumors

  2002cited by this paper
• Temporal and Spatial Patterns of Ovarian Gene Transcription Following an Ovulatory Dose of Gonadotropin in the Rat1

  2002cited by this paper
• Body size indices at different ages and epithelial ovarian cancer risk.

  2002cited by this paper
• Menopausal hormone replacement therapy and risk of ovarian cancer.

  2002cited by this paper
• Gonadotropin stimulation of MLS human epithelial ovarian carcinoma cells augments cell adhesion mediated by CD44 and by alpha(v)-integrin.

  2002cited by this paper
• Dynamic alterations of the extracellular environment of ovarian surface epithelial cells in premalignant transformation, tumorigenicity, and metastasis

  2002cited by this paper
• Proliferation of rhesus ovarian surface epithelial cells in culture: lack of mitogenic response to steroid or gonadotropic hormones.

  2002cited by this paper
• Differential expression of activin/inhibin subunit and activin receptor mRNAs in normal and neoplastic ovarian surface epithelium (OSE).

  2001cited by this paper

• Protein markers of ovarian cancer and its subtypes: insights from proteome-wide Mendelian randomisation analysis

  2025cites this paper
• Evaluating ovarian function in infertile patients: the combined diagnostic utility of anti-müllerian hormone and angiopoietin-like protein 8

  2025cites this paper
• Treatment of ovarian cancer: From the past to the new era (Review)

  2025cites this paper
• Ovarian cancer detection and prognosis: Unveiling circRNAs potential.

  2025cites this paper
• Prolonging youth or prolonging perimenopause? Beware the Monkey's Paw.

  2025cites this paper
• Effects of royal jelly on ovary cancer cells proliferation and apoptosis

  2025cites this paper
• Stress regulatory hormones and cancer: the contribution of epinephrine and cancer therapeutic value of beta blockers

  2025cites this paper
• FSH induces EMT in ovarian cancer via ALKBH5-regulated Snail m6A demethylation

  2024cites this paper
• Elevated chorionic gonadotropic hormone in transgenic mice induces parthenogenetic activation and ovarian teratomas.

  2024cites this paper
• Ovarian tumors in the pediatric population: An update.

  2024cites this paper
• Combined Autologous Breast Reconstruction and Gynecologic Procedures: Does Timing Affect Clinical and Patient‐Reported Outcomes?

  2024cites this paper
• Proliferative Effects of Curcuma zedoaria Extract on Ovarian Tumor Cells

  2024cites this paper
• Reply to "glycosylation of FSH and cancer".

  2024cites this paper
• Cytotoxic Activity of Novel GnRH Analogs Conjugated with Mitoxantrone in Ovarian Cancer Cells

  2024cites this paper
• From desert flora to cancer therapy: systematic exploration of multi-pathway mechanisms using network pharmacology and molecular modeling approaches

  2024cites this paper
• Identification of Ovarian Cancer Using in Silico-Based Analysis of the Downregulated Expressed miRNAs

  2023cites this paper
• Analysis of factors related to the incidence of epithelial ovarian cancer

  2023cites this paper
• An epigenetic hypothesis for ovarian cancer prevention by oral contraceptive pill use

  2023cites this paper
• Seasonal changes in endoplasmic reticulum stress and steroidogenesis in the ovary of the wild ground squirrels (Citellus dauricus Brandt).

  2023cites this paper
• Seasonal Change in Adiponectin Associated with Ovarian Morphology and Function in Wild Ground Squirrels (Citellus dauricus Brandt)

  2022cites this paper
• Analysis of Prediagnostic Circulating Levels of Gonadotropins and Androgens with Risk of Epithelial Ovarian Cancer

  2022cites this paper
• GPR12 Inhibits Apoptosis in Epithelial Ovarian Cancer via the Activation of ERK1/2 Signaling

  2022cites this paper
• "Reproductive Hormones and Implication of Synthetic Hormonal Preparations: Current Status"

  2021cites this paper
• ERβ Regulation of Gonadotropin Responses during Folliculogenesis

  2021cites this paper
• Relationship between 17𝜷 estradiol (17𝜷E) levels and Catechol -O- methyltransferase (COMT) levels in ovarian cancers

  2021cites this paper
• Long-term effect of repeated deslorelin acetate treatment in bitches for reproduction control.

  2021cites this paper
• Comorbidities and inflammation associated with ovarian cancer and its influence on SARS-CoV-2 infection

  2021cites this paper
• Expression of Catechol O methyl transferase (COMT) with the contrasting effects of 17β estradiol (E2): Implications for the mechanism of estrogen-induced ovarian carcinogenesis.

  2020cites this paper
• Reduced Gonadotrophin Receptor Expression Is Associated with a More Aggressive Ovarian Cancer Phenotype

  2020cites this paper
• What are the mechanisms of action of the different contraceptive methods to reduce the risk of ovarian cancer?

  2020cites this paper
• Pathogenesis of ovarian cancer

  2020cites this paper
• DEAD-Box Helicase 4 (Ddx4)+ Stem Cells Sustain Tumor Progression in Non-Serous Ovarian Cancers

  2020cites this paper
• Follicle-stimulating hormone promotes the proliferation of epithelial ovarian cancer cells by activating sphingosine kinase

  2020cites this paper
• Risk Factors for Ovarian Cancer

  2020cites this paper
• Estrogen enhances the proliferation and migration of ovarian cancer cells by activating transient receptor potential channel C3

  2020cites this paper
• Environmental toxin exposure in polycystic ovary syndrome women and possible ovarian neoplastic repercussion

  2020cites this paper
• Association of Anti-Mullerian Hormone, Follicle-Stimulating Hormone, and Inhibin B with Risk of Ovarian Cancer in the Janus Serum Bank

  2020cites this paper
• Targeting Membrane Receptors of Ovarian Cancer Cells for Therapy.

  2019cites this paper
• Small Molecule Follicle-Stimulating Hormone Receptor Agonists and Antagonists

  2019cites this paper
• Double ovarian tumour in the mare: Case report.

  2019cites this paper
• Ovarian Cancer Incidence in the Multi-Ethnic Asian City-State of Singapore 1968-2012

  2019cites this paper
• Thyroid Cancer Benefits the Prognosis of Ovarian Cancer: A SEER-Based Study

  2019cites this paper
• Association of hCG and LHCGR expression patterns with clinicopathological parameters in ovarian cancer.

  2019cites this paper
• Follicle-stimulating hormone promoted pyruvate kinase isozyme type M2-induced glycolysis and proliferation of ovarian cancer cells

  2019cites this paper
• Clinicopathological and prognostic values of ALDH1 in epithelial ovarian cancer: a meta-analysis

  2019cites this paper
• Epithelial Ovarian Cancer Prevention

  2019cites this paper
• Molecular Mechanisms of Action of FSH

  2019cites this paper
• Follicle ‐ stimulating hormone promoted pyruvate kinase isozyme type M 2 ‐ induced glycolysis and proliferation of ovarian cancer cells

  2019cites this paper
• Genome-wide Analysis of Common Copy Number Variation and Epithelial Ovarian Cancer Risk

  2019cites this paper
• epithelial ovarian cancer risk wide analysis of common copy number variation and - Genome

  2019cites this paper
• Effects of Endocrine-Disrupting Chemicals and Epigenetic Modifications in Ovarian Cancer: A Review

  2018influential citation
• MS-5, a Naphthalene Derivative, Induces the Apoptosis of an Ovarian Cancer Cell CAOV-3 by Interfering with the Reactive Oxygen Species Generation

  2018cites this paper
• Oxidative stress in female cancers

  2018cites this paper
• Gonadotropins and Their Analogs: Current and Potential Clinical Applications

  2018cites this paper
• Low fertility may be a significant determinant of ovarian cancer worldwide: an ecological analysis of cross- sectional data from 182 countries

  2018cites this paper
• Driving gonadotrophin hormone receptor signalling; the role of membrane trafficking.

  2018cites this paper
• Follicle-Stimulating Hormone Is an Autocrine Regulator of the Ovarian Cancer Metastatic Niche Through Notch Signaling

  2018cites this paper
• Mangiferin induces apoptosis in human ovarian adenocarcinoma OVCAR3 cells via the regulation of Notch3

  2017cites this paper
• EPIDEMIOLOGICAL, CLINICAL, AND PROGNOSTIC FACTORS IN ADULT-TYPE OVARIAN GRANULOSA CELL TUMORS

  2017cites this paper
• Pathogenesis of ovarian cancer: current perspectives

  2017cites this paper
• OVARIAN CANCER STEM CELLS IN CHEMORESISTANCE

  2017cites this paper
• Fluorescence resonance energy transfer usage to track the sequence promoter changes in CGB5 gene in ovarian cancer patients.

  2017cites this paper
• England, Gary C.W. and White, Rob (2016) Incomplete ovarian tissue removal in female dogs and cats. In Practice, 38 (7). pp. 315-326. ISSN 2042-7689

  2017cites this paper
• Gonadotropins promote human ovarian cancer cell migration and invasion via a cyclooxygenase 2-dependent pathway.

  2017cites this paper
• Incomplete ovarian tissue removal in female dogs and cats

  2016cites this paper
• The Role of Steroid Hormones, GREB1, and Reproductive Status in Ovarian Cancer Progression

  2016influential citation
• Follicle Depletion Provides a Permissive Environment for Ovarian Carcinogenesis

  2016cites this paper
• Thyrostimulin-TSHR signaling promotes the proliferation of NIH:OVCAR-3 ovarian cancer cells via trans-regulation of the EGFR pathway

  2016cites this paper
• An Investigation on a Novel Anti-tumor Fusion Peptide of FSH33-53-IIKK

  2016cites this paper
• [Impact of gonadotropins in women suffering from cancer].

  2016cites this paper
• β-arrestins regulate gonadotropin receptor-mediated cell proliferation and apoptosis by controlling different FSHR or LHCGR intracellular signaling in the hGL5 cell line.

  2016cites this paper
• Gankyrin facilitates follicle-stimulating hormone-driven ovarian cancer cell proliferation through the PI3K/AKT/HIF-1α/cyclin D1 pathway

  2016cites this paper
• Early and multiple origins of metastatic lineages within primary tumors

  2016cites this paper
• Elevated ZEB 2 and c-myc expression and their clinical significance in the epithelial ovarian cancer

  2016cites this paper
• Impact des gonadotrophines chez des patientes traitées pour cancer

  2016cites this paper
• Contribution des effets ciblés et non ciblés en radioimmunothérapie alpha et Auger de carcinoses péritonéales

  2016cites this paper
• The effects of hyperglycemia on glucose metabolism in epithelial ovarian cancer

  2016cites this paper
• Association of intimate partner vasectomy, use of long-acting progestogen-based contraceptives and intra-uterine contraceptive devices with risk of ovarian cancer.

  2016influential citation
• Therapeutic Potential of Human Chorionic Gonadotropin Against Painful Bladder Syndrome/Interstitial Cystitis

  2016cites this paper
• The Role of Estradiol-17 β and Type IV Collagen on Gpr 55 Gene Expression that Contributed to Increase Skov-3 Ovarian Cancer Cell Line Proliferation

  2015cites this paper
• The role of free beta subunit of human chorionic gonadotropin in high-grade serous cancer

  2015cites this paper
• Lack of Rev7 function results in development of tubulostromal adenomas in mouse ovary.

  2015cites this paper
• High Expressions of Lgr5 and ALDH1 in Primary Epithelial Ovarian Cancer Correlate with Advanced Tumor Stage and Grade as well as Poor Prognosis of the Patients

  2015cites this paper
• Ovarian cancer: involvement of the matrix metalloproteinases.

  2015cites this paper
• MicroRNA-148a inhibits the proliferation and promotes the paclitaxel-induced apoptosis of ovarian cancer cells by targeting PDIA3.

  2015cites this paper
• MicroRNA-148 a inhibits the proliferation and promotes the paclitaxel-induced apoptosis of ovarian cancer cells by targeting PDIA 3

  2015cites this paper
• Global Deletion of Trp53 Reverts Ovarian Tumor Phenotype of the Germ Cell–Deficient White Spotting Variant (Wv) Mice

  2015cites this paper
• OCT4 mediates FSH-induced epithelial-mesenchymal transition and invasion through the ERK1/2 signaling pathway in epithelial ovarian cancer.

  2015cites this paper
• Does ovarian stimulation for IVF increase gynaecological cancer risk? A systematic review and meta-analysis.

  2015cites this paper
• Menopause and ovarian cancer risk : mechanisms and experimental support

  2015cites this paper
• Genetic Models for the Study of Luteinizing Hormone Receptor Function

  2015cites this paper
• Development of Follicle-Stimulating Hormone Receptor Binding Probes to Image Ovarian Xenografts

  2015influential citation
• Development of a Mouse Model of Menopausal Ovarian Cancer

  2014cites this paper
• microRNA-206 overexpression inhibits cellular proliferation and invasion of estrogen receptor α-positive ovarian cancer cells.

  2014cites this paper
• Targeting of follicle stimulating hormone peptide-conjugated dendrimers to ovarian cancer cells.

  2014cites this paper
• Method development approaches towards the identification and validation of disease-related protein targets

  2014cites this paper
• Modulation of the ovarian cancer humoral response by tumor-derived exosomes.

  2014cites this paper
• Wpływ procesu starzenia się ludzkiego mezotelium otrzewnowego na wykładniki progresji raka jajnika w modelu komórkowym i zwierzęcym

  2014cites this paper
• Ovarian surface epithelium receptors during pregnancy and estrus cycle of rats with emphasis on steroids and gonadotropin fluctuation.

  2014cites this paper
• Estrogen Biosynthesis and Action in Ovarian Cancer

  2014cites this paper